Bitcoin
74204.05
-241.95
-0.33%
Crude Oil
91.86
-7.22
-7.86%
Gold
4863.6
+96.2
+1.98%
Copper
6.08
+0.09
+1.55%
Silver
79.54
+3.88
+4.87%
Dow Jones
48218.25
+301.67
+0.63%
SP500
6965.21
+78.97
+1.13%
NASDAQ
23183.74
+280.85
+1.21%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
12.3
+99.00%
Top Gainers
749,212
Top Gainers
2695
+80.00%
Top Gainers
144,228
Top Gainers
2.13
+46.01%
Top Gainers
4,647,138
Top Gainers
10.49
+41.85%
Top Gainers
170,650
Top Gainers
24.65
+41.05%
Top Gainers
265,059
Top Gainers
8.62
+32.25%
Top Gainers
2,019,219
Top Gainers
42.37
+27.54%
Top Gainers
1,194,234
Top Gainers
127.05
+25.84%
Top Gainers
252,159
Top Gainers
7.75
+25.81%
Top Gainers
123,311
Top Gainers
2.11
+25.59%
Top Gainers
347,843
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
82700
-119.71%
Top Loosers
763,022
Top Loosers
10
-45.00%
Top Loosers
747,066
Top Loosers
1.04
-38.46%
Top Loosers
1,038,030
Top Loosers
1.52
-38.16%
Top Loosers
2,097,254
Top Loosers
3.55
-38.03%
Top Loosers
126,676
Top Loosers
2.4449
-25.16%
Top Loosers
2,387,775
Top Loosers
14.52
-22.31%
Top Loosers
327,974
Top Loosers
2.19
-20.09%
Top Loosers
2,689,077
Top Loosers
41.635
-17.88%
Top Loosers
1,916,224
Top Loosers
6.18
-16.83%
Top Loosers
1,225,416
Top Loosers

In Today's Headlines

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR
03:30
14 Apr 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv- 01951, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nektar securities between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Blink Charging Teams with The Rosemyr Corporation to Celebrate Earth Day at Morganton Plaza in North Carolina
03:30
14 Apr 2026
Blink Charging Teams with The Rosemyr Corporation to Celebrate Earth Day at Morganton Plaza in North Carolina

Blink Offering Two Hours of Free EV Charging at Morganton Plaza and Week-Long Charging Credit Promotion starting Earth Day (April 22, 2026)

Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc.and Certain Officers – ENPH
03:28
14 Apr 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc.and Certain Officers – ENPH

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ: ENPH) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-01380, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Enphase securities between April 22, 2025 and October 28, 2025 both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

EOSE SHAREHOLDER UPDATE: Eos Energy (EOSE) Facing Securities Class Action Alleging Misstatements on Production Scale, Guidance – Hagens Berman
03:23
14 Apr 2026
EOSE SHAREHOLDER UPDATE: Eos Energy (EOSE) Facing Securities Class Action Alleging Misstatements on Production Scale, Guidance – Hagens Berman

SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Eos Energy Enterprises (NASDAQ: EOSE), seeking to represent investors who purchased Eos securities between November 5, 2025 and February 26, 2026. The lawsuit follows the 39% decline in the price of Eos shares on Feb. 26, 2026, which wiped out hundreds of millions of dollars of the company's market capitalization.

Johnson & Johnson's Spravato sales growth signals upside for psychedelics peers like AtaiBeckley
03:22
14 Apr 2026
Johnson & Johnson's Spravato sales growth signals upside for psychedelics peers like AtaiBeckley

Johnson & Johnson (NYSE:JNJ)'s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of strong sales growth, with Jefferies analysts pointing to implications for companies such as AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) and peers developing next-generation mental health treatments. Spravato (esketamine nasal spray), which is approved for treatment-resistant depression (TRD), generated $468 million in global sales in the first quarter of 2026, representing a 46% increase year over year.

APH's IT Datacom Growth Surges With AI Push: What Lies Ahead?
03:20
14 Apr 2026
APH's IT Datacom Growth Surges With AI Push: What Lies Ahead?

Amphenol's IT datacom unit posts triple-digit growth, driven by AI demand, with record orders and strong guidance signaling sustained momentum in data center expansion.

NU Stock Consolidates Over the Past Six Months: Buy, Hold, or Sell?
03:20
14 Apr 2026
NU Stock Consolidates Over the Past Six Months: Buy, Hold, or Sell?

Nu Holdings shows strong growth, scale and profitability, but a premium valuation and range-bound stock keep its near-term upside in check.

Life Time to Report First Quarter 2026 Financial Results on May 5, 2026
03:19
14 Apr 2026
Life Time to Report First Quarter 2026 Financial Results on May 5, 2026

CHANHASSEN, Minn., April 14, 2026 /PRNewswire/ -- Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced details for its first quarter 2026 earnings conference call.

Revolution Medicines: 'Strong Buy' On Daraxonrasib Win And Expansions Underway
03:18
14 Apr 2026
Revolution Medicines: 'Strong Buy' On Daraxonrasib Win And Expansions Underway

Revolution Medicines (RVMD) remains a 'Strong Buy' following statistically significant phase 3 RASolute 302 results for daraxonrasib in 2nd-line metastatic PDAC. Company's daraxonrasib achieved median overall survival of 13.2 months vs. 6.7 months for chemotherapy in the ITT population [p < 0.0001]. Expansion opportunities include phase 3 RASolute 303 for 1st-line PDAC and additional late-stage trials in NSCLC and adjuvant settings.

Amanda Demanda: Lululemon PFAS Investigation Signals Litigation Risk for “Clean” Consumer Brands
03:17
14 Apr 2026
Amanda Demanda: Lululemon PFAS Investigation Signals Litigation Risk for “Clean” Consumer Brands

HOUSTON, April 14, 2026 (GLOBE NEWSWIRE) -- A new investigation by Ken Paxton into whether Lululemon Athletica, Inc,  sold apparel containing Per- and polyfluoroalkyl substances could mark a broader shift in how product liability cases are built and litigated, according to consumer safety attorney Amanda Demanda of Amanda Demanda Injury Lawyers .